SSY GROUP: Benzenesulfonic Acid Amlodipine Tablets Obtained Drug Production Registration Approval
智通財經 APP 訊，石四藥集團發佈公告，本集團已取得中國國家藥品監督管理局有關苯磺酸左氨氯地平片 (5mg 及 2.5mg) 的藥品生產註冊批件，均屬於化學藥品第 4 類，視同通過一致性評價。苯磺酸左氨氯地平片主要用於高血壓、慢性穩定性心絞痛及血管痙攣性心絞痛的治療，可單獨應用或與其他藥物聯合應用。
智通財經 APP 訊，石四藥集團 (02005) 發佈公告，本集團已取得中國國家藥品監督管理局有關苯磺酸左氨氯地平片 (5mg 及 2.5mg) 的藥品生產註冊批件，均屬於化學藥品第 4 類，視同通過一致性評價。
苯磺酸左氨氯地平片主要用於高血壓、慢性穩定性心絞痛及血管痙攣性心絞痛的治療，可單獨應用或與其他藥物聯合應用。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments